Stewart RAH, et al. - In this investigation, researchers ascertained if darapladib treatment has any effect on cognitive function, and assessed whether other potentially modifiable risk factors may be correlated with cognitive function in patients with stable coronary heart disease. They found that cognitive performance was related to modifiable cardiovascular risk factors, educational level, and global region, but was not influenced by darapladib in patients with stable coronary heart disease.